3/26
04:38 pm
tlph
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
Medium
Report
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
1/29
05:43 am
tlph
Talphera, Inc. (NASDAQ: TLPH) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Talphera, Inc. (NASDAQ: TLPH) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
1/28
07:17 am
tlph
Talphera, Inc. (NASDAQ: TLPH) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock.
Low
Report
Talphera, Inc. (NASDAQ: TLPH) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock.
1/21
08:12 am
tlph
Talphera, Inc. (NASDAQ: TLPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Talphera, Inc. (NASDAQ: TLPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
1/14
08:43 am
tlph
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study [Yahoo! Finance]
Medium
Report
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study [Yahoo! Finance]
1/14
08:30 am
tlph
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
Medium
Report
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study